More Good Days

High-Level Overview

MoreGoodDays is a health tech startup developing a digital app-based program for chronic pain management and recovery, targeting conditions like fibromyalgia, back pain, and whiplash. It serves individuals suffering from chronic pain—estimated at 1.6 billion worldwide—by delivering evidence-based, neuroscience-backed content, activities, weekly live clinician sessions, and on-demand support from psychologists and physiotherapists to reduce pain sensations, boost physical function, and enhance emotional wellbeing.[1][2] The 12-week program solves key barriers like specialist shortages by using specialized content that enables generalist psychologists, achieving reported outcomes such as 80% of clients experiencing significant pain improvement and 76% noting better mental health.[1][2] Backed by seed investors including Blackbird VC, it demonstrates strong early growth: founder-built MVP in under five months, organic customer acquisition, Medicare reimbursements, and paying users within three months of launch without ads.[1]

Origin Story

Founded by Neala Cowie and co-founder/CMO Helena Ngo, MoreGoodDays emerged from Neala's personal and professional journey addressing global health inequities. With experience at BCG, the International Rescue Committee (leading R&D innovations in Sierra Leone, Kenya, and Jordan), and NESTA, Neala self-taught Webflow to build the MVP—a mobile-friendly 12-week program with narrated content—in under five months.[1] Pivotal early traction included structuring for Medicare reimbursements, launching via Startmate (where Helena joined as a fellow), and securing dozens of referring doctors plus paying customers organically in three months.[1] This product-led hustle, blending Neala's health innovation expertise with lived insights into chronic pain, rapidly validated the model and attracted seed funding led by Blackbird VC, alongside Giant Leap, Side Stage Ventures, The Snow Foundation, and LaunchVic’s Alice Anderson Fund.[1]

Core Differentiators

• Evidence-Based, Condition-Specific Design: Tailored digital content from neuroscience breakthroughs, peer-reviewed by clinicians and researchers with lived chronic pain experience, paired with 1:1 coaching—allowing generalist psychologists to treat specialist shortages effectively.[1][2]
• Proven Outcomes and Accessibility: 80% client-reported pain reduction, 76% mental health gains; app-based (mobile/browser) with live sessions, expert FAQs, and scalable reimbursements like Medicare, making treatment affordable and reachable for 1.6 billion sufferers.[1][2]
• Founder-Driven Product Speed: MVP built solo in months without ads, emphasizing ease-of-use, psychological support, and real-world validation through organic doctor referrals and rapid user growth.[1]
• Holistic Recovery Focus: Improves not just pain but physical function, emotional health, and life re-engagement, with multidisciplinary team input for scientific rigor.[2]

Role in the Broader Tech Landscape

MoreGoodDays rides the digital therapeutics wave in health tech, leveraging pain neuroscience advances to democratize care amid a global chronic pain crisis affecting 1.6 billion, where specialist access is severely limited.[1][2] Timing aligns with post-pandemic telehealth normalization, rising Medicare coverage for digital programs, and investor interest in scalable behavioral health solutions—evident in seed backing from top VCs like Blackbird.[1] Market tailwinds include exploding demand for non-pharma pain management (e.g., fibromyalgia, back pain) and app-based scalability, reducing costs versus in-person therapy.[1][2] It influences the ecosystem by pioneering reimbursable digital psychology tools, inspiring similar product-led health startups, and proving rapid founder execution can disrupt supply-constrained fields like chronic care.[1]

Quick Take & Future Outlook

Next for MoreGoodDays: expand beyond fibromyalgia to broader chronic conditions, scale clinician networks, and deepen Medicare/private payer integrations for nationwide (and global) reach, building on MVP momentum.[1][2] Trends like AI-personalized therapeutics, VR pain modulation, and value-based care will accelerate growth, while regulatory nods for digital health could unlock exponential adoption. Its influence may evolve from niche innovator to category leader, empowering millions toward "more good days" by blending tech accessibility with proven science—proving one founder's bold vision can transform chronic pain treatment at scale.[1][2]